Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary) ; Grass pollen allergy immunotherapy (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis; Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors LETI Pharma GmbH
- 08 Aug 2011 New trial record